NO20031045D0 - Ny polymorf form av 17-<beta>-(N-tert.butylkarbamoyl)-4-aza-5- <alfa>-ANDROST-1-en-3-on og en fremgangsmåte for fremstilling av den - Google Patents

Ny polymorf form av 17-<beta>-(N-tert.butylkarbamoyl)-4-aza-5- <alfa>-ANDROST-1-en-3-on og en fremgangsmåte for fremstilling av den

Info

Publication number
NO20031045D0
NO20031045D0 NO20031045A NO20031045A NO20031045D0 NO 20031045 D0 NO20031045 D0 NO 20031045D0 NO 20031045 A NO20031045 A NO 20031045A NO 20031045 A NO20031045 A NO 20031045A NO 20031045 D0 NO20031045 D0 NO 20031045D0
Authority
NO
Norway
Prior art keywords
androst
butylcarbamoyl
aza
tert
beta
Prior art date
Application number
NO20031045A
Other languages
English (en)
Other versions
NO20031045L (no
Inventor
Satyanarayana M Reddy
T S Rajan
Brahmeshwara M V N Rao
K Vyas
Vishnuvardhana S Reddy
Shashi K Rekha
Original Assignee
Reddys Lab Ltd Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reddys Lab Ltd Dr filed Critical Reddys Lab Ltd Dr
Publication of NO20031045D0 publication Critical patent/NO20031045D0/no
Publication of NO20031045L publication Critical patent/NO20031045L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/005—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20031045A 2000-09-07 2003-03-06 Ny polymorf form av 17-<beta>-(N-tert.butylkarbamoyl)-4-aza-5- <alfa>-ANDROST-1-en-3-on og en fremgangsmåte for fremstilling av samme NO20031045L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN737DE2000 2000-09-07
PCT/US2001/019546 WO2002020553A1 (en) 2000-09-07 2001-06-19 NOVEL POLYMORPHIC FORM OF 17-β-(N-TER.BUTYL CARBAMOYL)-4-AZA-5-α-ANDROST-1-EN-3-ONE AND A PROCESS FOR PREPARING IT

Publications (2)

Publication Number Publication Date
NO20031045D0 true NO20031045D0 (no) 2003-03-06
NO20031045L NO20031045L (no) 2003-04-29

Family

ID=11097081

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031045A NO20031045L (no) 2000-09-07 2003-03-06 Ny polymorf form av 17-<beta>-(N-tert.butylkarbamoyl)-4-aza-5- <alfa>-ANDROST-1-en-3-on og en fremgangsmåte for fremstilling av samme

Country Status (12)

Country Link
EP (1) EP1322663A1 (no)
JP (1) JP2004508380A (no)
AU (1) AU6991101A (no)
BR (1) BR0113732A (no)
CA (1) CA2422159A1 (no)
HU (1) HUP0300937A3 (no)
IL (1) IL154785A0 (no)
NO (1) NO20031045L (no)
NZ (1) NZ525116A (no)
PL (1) PL361014A1 (no)
WO (1) WO2002020553A1 (no)
ZA (1) ZA200302554B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2206065B1 (es) * 2002-10-31 2005-08-16 Ragactives, S.L. Procedimiento para la obtencion de la forma polimorfica i de finasterida.
EP1651661B1 (en) * 2003-07-03 2008-08-27 Cipla Ltd. Process for the preparation of finasteride form i
CN1294913C (zh) * 2004-12-23 2007-01-17 鲁南制药集团股份有限公司 含有非那雄胺与环糊精或其衍生物的药物组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ225100A (en) * 1987-06-29 1991-09-25 Merck & Co Inc Reaction of steroids (including 4-azasteroids) with a silylating agent in the presence of a quinone to introduce a delta' double bond and silylated intermediates
US5237061A (en) * 1988-10-31 1993-08-17 Merck & Co., Inc. Methods of synthesizing benign prostatic hypertropic agents and their intermediates
US5021575A (en) * 1989-11-13 1991-06-04 Merck & Co., Inc. Method for introducing a 1,2 double bond into azasteroids
US5091534A (en) * 1990-08-27 1992-02-25 Merck & Co., Inc. Trialkylsilyl trifluoromethanesulfonate mediated α-methylenic carbon functionalization of 4-AZA-5α-androstan-3-one steroids
US5468860A (en) * 1992-11-19 1995-11-21 Merck & Co., Inc. New finasteride processes

Also Published As

Publication number Publication date
HUP0300937A2 (en) 2007-02-28
NO20031045L (no) 2003-04-29
NZ525116A (en) 2004-11-26
AU6991101A (en) 2002-03-22
EP1322663A1 (en) 2003-07-02
CA2422159A1 (en) 2002-03-14
ZA200302554B (en) 2004-02-19
WO2002020553A1 (en) 2002-03-14
IL154785A0 (en) 2003-10-31
PL361014A1 (en) 2004-09-20
HUP0300937A3 (en) 2007-10-29
BR0113732A (pt) 2003-07-29
JP2004508380A (ja) 2004-03-18

Similar Documents

Publication Publication Date Title
NO20004156L (no) MTO-reaktor med hurtig-fluidiserende bed
DK1180518T3 (da) 5-pyridyl-1,3-azolforbindelser, fremgangsmåde til fremstilling deraf og anvendelse deraf
NO20035530D0 (no) Sementeringshode
DE60101069D1 (de) Siliziumkarbid und Verfahren zu seiner Herstellung
DE60227390D1 (de) Dehnbarer vliesstoff und methode zu dessen herstellung
DE60105218D1 (de) Siliciumkarbid und Verfahren zu seiner Herstellung
DE60227605D1 (de) Feines alpha-Aluminiumoxidpulver und Verfahren zu dessen Herstellung
EE200100574A (et) Uued ühendid, nende valmistamise meetod ning kasutamine
EE200100383A (et) L-fenüülefriinvesinikkloriidi valmistamise meetod
DE50101059D1 (de) Zylinderkopfdichtung und Verfahren zu ihrer Herstellung
DK1138677T3 (da) Fremgangsmåde til fremstilling af 11-amino-3-chlor-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c,f][1,2]-thiazepin og anvendelse til syntese af tianeptin
DE60019691D1 (de) Siliziumkarbid und Verfahren zu seiner Herstellung
DE60206409D1 (de) Siliziumkarbidfilter und verfahren zu dessen herstellung
NO20025069L (no) Ny stabil krystall av tiazolidindionderivat og fremgangsmÕte for fremstilling av det samme
ATE259825T1 (de) Hemihydrat von 16.alpha.-bromoepiandrosterone
NO20011804L (no) En forbedret fremgangsmåte for fremstilling av nye antidiabetiske midler
NO20032440D0 (no) Fremgangsmåte for fremstillingen av iopamidol og de nye intermediater deri
NO20031045D0 (no) Ny polymorf form av 17-&lt;beta&gt;-(N-tert.butylkarbamoyl)-4-aza-5- &lt;alfa&gt;-ANDROST-1-en-3-on og en fremgangsmåte for fremstilling av den
NO20001909D0 (no) Fremgangsmõte og anlegg for fremstilling av 1,2-dikloretan
NO20025461D0 (no) Nye formuleringer av &lt;alfa&gt;-(2,4-disulfofenyl)-N-tert- butylnitron
NO20005932D0 (no) Nye forbindelser avledet fra &lt;alfa&gt;-D-xylose, fremgangsmåte for fremstilling av slike og terapeutisk anvendelse
NO20000965L (no) FremgangsmÕte for fremstilling av veksthormon-utskillende forbindelser
EE200100656A (et) Kristallilise asabitsüklo(2,2,2)oktaan-3-amiintsitraadi polümorfid ja nende ravimsegud
NO20011480L (no) Fremgangsmåte for fremstilling av (-)&lt;alfa&gt;- (difluormetyl)ornitin-monohydrokloridmonohydrat
NO20014077L (no) Fremgangsmåte for krystallisering av N-(4-trifluormetylfenyl)- 5-metyl-isoksazol-4-karboksamid

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application